Dr. Peymani is a clinical/pharmaco-epidemiologist with experience in universities, research centers, institutes, industry and hospitals in the Netherlands, Switzerland, and Canada. He obtained his fellowship in drug safety and pharmacovigilance from the University Hospital and University of Zurich, Switzerland, a Ph.D. in clinical epidemiology (pharmacoepidemiology) from Shiraz University, and his Pharm.D. degree from the Faculty of Pharmacy, Shiraz University. Prior to joining the THRiVE Lab, he studied safety medication among pregnant people and children supported by a Canadian Mother-Child COLlaborative Training Platform (CAMCCO-L) postdoctoral bursary award. His main research interests are drug/healthcare utilization, real-world evidence generation, and pregnancy and mother-infant health.